Announcement

Collapse

Advertising Inquiries

See more
See less

Performance-Enhancing Effects of Deca Durabolin Are Celebrated in Medicine

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Performance-Enhancing Effects of Deca Durabolin Are Celebrated in Medicine

    The scientific community is becoming increasingly excited by the therapeutic use of anabolic steroids for a variety of medical treatments. The same performance-enhancing effects that are demonized in society, and sports in particular, are celebrated for their therapeutic potential. The unfortunate war on steroids and resulting hysteria have regrettably delayed research into this class of medicines for decades. However, it appears the therapeutic value of steroids can not be overlooked indefinitely as scientific progress marches on in spite of morally-driven obstacles.

    Eric Hohmann and colleagues at Central Queensland University experiemented with the use of the anabolic steroid nandrolone decanoate (trade name: Deca Durabolin) after total knee replacement surgery. They summed up the reason that anabolic steroids are a viable and interesting subject for scientific inquiry:

    Recently there is an increasing interest in using anabolic steroids for medical conditions such as age related muscle wasting and increase muscle mass in patients with secondary wasting syndromes such as HIV. The main effects are positive anabolic actions on the musculoskeletal system influencing lean body mass, muscle size, strength, protein and bone metabolism and collagen synthesis. The effect is dose dependent and significant increases in strength occur only with doses of 300 mg testosterone or more. Side effects are rare and mostly benign and reversible.

    Hohmann’s study involved a small group of elderly individuals undergoing total knee arthroplasty (knee replacement). The treatment protocol involved 50mg of nandrolone decanoate via intramuscular injection every two weeks for the 6 months; the control group received an equivalent volume injection containing an inert saline solution.

    Many bodybuilders will be surprised to learn that such low dosages of Deca had any effect on strength. There may be several shortcomings to the study design. Nonetheless, the strength gains in the steroid group were significantly greater than those in the control group.

    The strength gains didn’t translate directly to an improvement in functional tests. However, research has shown that post-operative strength is a good predictor of long-term prognosis after this type of surgery.

    The strength gains were retained for 12 months – a full six months after discontinuation of the steroid cycle – and remained significantly better than the control group. The researchers did not observe any side effects from the nandrolone steroid cycle.

    The researchers apparently did not account for any potential suppressive effects of nandrolone decanoate on the functioning of the hypothalamus-pituitary-testicular axis (HPT axis). It is unclear if they measured total testosterone, luteneizing hormone (LH), follicle stimulating hormone (FSH) or any other variables with laboratory blood tests.

    According the Michael Scally, M.D., all anabolic steroids, and nandrolone in particular, are suppressive to the HPT axis. The degree of suppression varies in severity and duration. This causes a resulting condition known as anabolic steroid induced hypogonadism (ASIH) that is marked by a reduction in testosterone naturally produced by the body. ASIH is a side effect that is well-documented and easily treated.

    It is possible that results could have been improved with a better steroid cycle design and a post cycle therapy protocol. Scally has described the failure of researchers to address ASIH as one of the major shortcomings of medical research into anabolic steroids.

    Special thanks to Michael Scally, M.D. for his diligence in staying on top of anabolic steroid medical research and sharing this study with MESO-Rx.

    Hohmann E, Tetsworth K, Hohmann S, Bryant AL. Anabolic steroids after total knee arthroplasty. A double blinded prospective pilot study. J Orthop Surg Res;5:93. Journal of Orthopaedic Surgery and Research.

  • #2
    :) :)

    Comment


    • #3
      Damm, that's the last thing I want, I prefer the cult status and widespread ignorance!

      Comment


      • #4
        You have to be careful reading this stuff. Your better off looking at the actual study so its not bias. Its not really new news regarding Deca. Deca has been used for years to treat aids patients. Here is the actual study. It was done in Australia.


        Background
        Total knee arthroplasty is reported to improve the patient's quality of life and mobility. However loss of mobility and pain prior to surgery often results in disuse atrophy of muscle. As a consequence the baseline functional state prior to surgery may result in poorer outcome "post surgery" and extended rehabilitation may be required. The use of anabolic steroids for performance enhancement and to influence muscle mass is well established. The positive effects of such treatment on bone and muscle could therefore be beneficial in the rehabilitation of elderly patients. The purpose of this study was to investigate the effects of small doses of Nandrolone decanoate on recovery and muscle strength after total knee replacement and to establish the safety of this drug in multimorbid patients.

        Methods
        This study was designed as a prospective double blind randomized investigation. Five patients (treatment group) with a mean age of 66.2 (58-72), average BMI of 30.76 (24.3-35.3) received 50 mg nandrolone decanoate intramuscular bi-weekly for 6 months. The control group (five patients; mean age 65.2, range 59-72; average BMI 31.7, range 21.2-35.2) was injected with saline solution. "Pre-operatively" and "post-operatively" (6 weeks, 3,6,9 and 12 months) all patients were assessed using the knee society score (KSS), isokinetic strength testing and functional tests (a sit-to-stand and timed walking tests). In addition, a bone density scan was used preoperatively and 6 month postoperatively to assess bone mineral density.

        Results
        Whilst the steroid group generally performed better than the placebo group for all of the functional tests, ANOVA failed to reveal any significant differences. The steroid group demonstrated higher levels of quadriceps muscle strength across the postoperative period which reached significance at 3 (p = 0.02), 6 (p = 0.01), and 12 months (p = 0.02). There was a significant difference for the KSS at 6 weeks (p = 0.02), 6 (p = 0.02) and 12 month (p = 0.01). The steroid group demonstrated a reduction in the amount of bone mineral density at both the femur and lumbar spine from "pre-" to "post-surgery", however, these results did not reach significance (p < 0.05) using one-way ANOVA.

        Conclusions
        This project strongly suggests that the use of anabolic steroids result in an improved outcome as assessed by the KSS and significantly increases extensor strength. No side effects were seen in either the study or control group.

        Trial Registration Number
        Regional Health District: Register No. 03.05

        Human Research Ethics Committee University: Clearance Number: 04/03-19

        Comment

        Working...
        X